COVID‐19‐associated coagulopathy—Hypothesis: Are children protected due to enhanced thrombin inhibition by higher α2‐Macroglobulin macroglobulin (α2‐M)?

We are overwhelmed by scientific publications on clinical observations, virology, and epidemiology of SARS‐CoV‐2 infections. There is a growing body of evidence that hypercoagulability complicates COVID‐19, probably contributing to poor prognosis. This should stimulate further research into the pathogenesis of this procoagulant type of disseminated intravascular coagulation (DIC), and therapeutic options.1.Seitz R. Schramm W. DIC in COVID‐19:...